We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Amphion Innovations Plc | LSE:AMP | London | Ordinary Share | GB00B0DJNP99 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.15 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From May 2019 to May 2024
TIDMAMP
RNS Number : 3444I
Amphion Innovations PLC
24 March 2015
Amphion Innovations plc
Issue of Shares
London and New York, 24 March 2015 - Amphion Innovations plc (LSE: AMP) ("Amphion" or the "Company"), the developer of medical and technology businesses, today announces that, further to the announcements on 5 June 2014 and 9 September 2014, the Company has issued 1,298,646 ordinary shares to YA Global Master SPV, Ltd. at a price of GBP0.0266 per ordinary share as a share-based interest payment, which is equal to 95% of the average of the 5 daily Volume Weighted Average Prices from 9 March to 19 March. The shares represent 0.85% of the enlarged issued share capital.
Admission of the 1,298,646 new ordinary shares, ranking pari passu with the existing ordinary shares, is expected 1 April 2015. Following this allotment the total issued share capital of the Company will increase to 152,069,866 ordinary shares with each share holding one voting right.
For further information please contact
Amphion Innovations plc
Charlie Morgan,
+1 (212) 210 6224
Yellow Jersey PR
Dominic Barretto / Philip Ranger/ Fiona Walker
+44 7768 537 739
Panmure Gordon Limited
Freddy Crossley / Duncan Monteith (Corporate Finance)
Charles Leigh-Pemberton (Corporate Broking)
+44 020 7886 2500
Plumtree Capital Limited (Advisor to Amphion)
Stephen Austin
+44 207 183 2493
+1 646 568 7502
About Amphion Innovations plc
Amphion (LSE: AMP) builds shareholder value in emerging companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.
On the web: www.amphionplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLLFFEVDISFIE
1 Year Amphion Innovations Chart |
1 Month Amphion Innovations Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
